Social Theory & Health

, Volume 14, Issue 3, pp 312–331 | Cite as

Translational biomedicine in action: Constructing biomarkers across laboratory and benchside

Original Article

Abstract

This article, based on ethnographic research conducted in a major Italian institution specialising in cancer care and research, provides insight into the clinical and basic research laboratory practices articulated around an experimental protocol designed to develop a biomarker. The article adopts an ‘ecological’ perspective matured in the field of science and technology studies of the translational process and suggests that biomedical activities are multi-directional, and cannot be understood in reductionist terms, that is, as a two-way linear transfer of bio-knowledge from the bench to bedside and back. I propose the notion of technomimicry, in its dual acceptation in the clinical and experimental sense, to understand the cognitive, social and material strategies involved in the circuit of migration of heterogeneous materials and information across scientific laboratories and clinics. Clinical and experimental technomimicry theoretically capture the multi-directional and multi-modal process of the re-location of materials and bio-knowledge from one site to another. These concepts also highlight how the epistemological boundaries of the clinic and laboratory are required to be mutually adjusted and continuously realigned in order to translate laboratory facts into clinical activities, and clinical evidence into researchable issues.

Keywords

translational biomedicine personalised medicine oncology biomarkers clinical and experimental technomimicry ethnography 

References

  1. Abu El-Haj, N. (2007) The genetic reinscription of race. Annual Review of Anthropology 36: 283–300.CrossRefGoogle Scholar
  2. Allsop, J. and Mulcahy, L. (1996) Regulating Medical Work: Formal and Informal Controls. Buckingham, UK: Open University Press.Google Scholar
  3. Atkinson, P. (1995) Medical Talk and Medical Work. London: Sage.Google Scholar
  4. Atkinson, P., Glasner, P. and Greenslade, H. (eds.) (2007) New Genetics, New Identities. London: Routledge.Google Scholar
  5. Basik, M., Balducci, L. and Bregni, M. (2011) Personalized medicine: A comprehensive approach in oncology. Journal of Medicine and the Person 9(3): 89–90.CrossRefGoogle Scholar
  6. Berg, M. (1992) The construction of medical disposal: Medical sociology and medical problem solving in clinical practice. Sociology of Health & Illness 14(2): 151–180.CrossRefGoogle Scholar
  7. Berg, M. (1997) Rationalizing Medical Work: Decision-Support Techniques and Medical Practices. Cambridge, MA: MIT Press.Google Scholar
  8. Bowker, G.C. and Star, S.L. (1999) Sorting Things Out: Classification and Its Consequences. Cambridge, MA: MIT Press.Google Scholar
  9. Brosnan, C. and Michael, M. (2014) Enacting the ‘neuro’ in practice: Translational research, adhesion and the promise of porosity. Social Studies of Science 44(5): 680–700.CrossRefGoogle Scholar
  10. Brown, H. (2007) Translational cancer research in the USA. Molecular Oncology 1(1): 11–13.CrossRefGoogle Scholar
  11. Butler, D. (2008) Translational research: Crossing the valley of death. Nature 453(7197): 840–842.CrossRefGoogle Scholar
  12. Cambrosio, A., Keating, P., Bourret, P., Mustar, P. and Rogers, S. (2012) Genomic platforms and hybrid formations. In: P. Atkinson, P. Glasner and M. Lock (eds.) The Handbook of Genetics and Society: Mapping the New Genomic Era. New York: Routledge, pp. 502–520.Google Scholar
  13. Cambrosio, A., Keating, P., Mercier, S., Lewison, G. and Mogoutov, A. (2006b) Mapping the emergence and development of translational cancer research. European Journal of Cancer 42(18): 3140–3148.CrossRefGoogle Scholar
  14. Cambrosio, A., Keating, P., Schlich, T. and Weisz, G. (2006a) Regulatory objectivity and the generation and management of evidence in medicine. Social Science & Medicine 63(1): 189–199.CrossRefGoogle Scholar
  15. Cambrosio, A., Keating, P., Schlich, T. and Weisz, G. (2009) Biomedical conventions and regulatory objectivity a few introductory remarks. Social Studies of Science 39(5): 651–664.CrossRefGoogle Scholar
  16. Canguilhem, G. (1989) The Normal and The Pathological. New York: Zone Books.Google Scholar
  17. Charmaz, K. (2009) Shifting the grounds: Constructivist grounded theory methods. In: J.M. Morse, P.N. Stern, J. Corbin, B. Bowers, A.E. Clarke and K. Charmaz (eds.) Developing Grounded Theory: The Second Generation. Walnut Creek, CA: University of Arizona Press, pp. 127–193.Google Scholar
  18. Clarke, J.N. and James, S. (2003) The radicalised self: The impact on the self of the contested nature of the diagnosis of chronic fatigue syndrome. Social Science & Medicine 57(8): 1387–1395.CrossRefGoogle Scholar
  19. Clarke, A.E., Mamo, L., Fosket, J.R., Fishman, J.R. and Shim, J.K. (eds.) (2010) Biomedicalization: A theoretical and substantive introduction. In: Biomedicalization: Technoscientific Transformation of Health, Illness in the U.S. Durham, NC: Duke University Press, pp. 1–44.Google Scholar
  20. Clarke, A.E., Shim, J.K., Shostak, S. and Nelson, A. (2009) Biomedicalising genetic health, diseases and identities. In: P. Atkinson, P. Glasner and M. Lock (eds.) The Handbook of Genetics and Society: Mapping the New Genomic Era. New York: Routledge, pp. 21–40.Google Scholar
  21. Contopoulos-Ioannidis, D.G., Ntzani, E.E. and Ioannidis, J.P.A. (2003) Translation of highly promising basic science research into clinical applications. American Journal of Medicine 114(6): 477–484.CrossRefGoogle Scholar
  22. Cox, H. and Webster, A. (2013) Translating biomedical science into clinical practice: Molecular diagnostics and the determination of malignancy. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 17(4): 391–406.Google Scholar
  23. Crabu, S. (2014a) Nanomedicine in the making. Expectations, scientific narrations and materiality. Tecnoscienza: Italian Journal of Science & Technology Studies 5(1): 43–66.Google Scholar
  24. Crabu, S. (2014b) Give us a protocol and we will rise a lab. The shaping of the infra-structuring objects. In: A. Mongili and G. Pellegrino (eds.) Information Infrastructure(s): Boundaries, Contexts, Ecologies. Newcastle, UK: Cambridge Scholars Publishing, pp. 120–165.Google Scholar
  25. Derksen, L. (2000) Towards a sociology of measurement: The meaning of measurement error in the case of DNA profiling. Social Studies of Science 30(6): 803–845.CrossRefGoogle Scholar
  26. Epstein, S. (2007) Inclusion: The Politics of Difference in Medical Research. Chicago, IL: University of Chicago Press.CrossRefGoogle Scholar
  27. Evans, S. and Scarbrough, H. (2014) Supporting knowledge translation through collaborative translational research initiatives: ‘Bridging’ versus ‘blurring’ boundary-spanning approaches in the UK CLAHRC initiative. Social Science & Medicine 106(1): 119–127.CrossRefGoogle Scholar
  28. Fischer, M.J. (2012) Lively biotech and translational research. In: K.S. Rajan (eds.) Lively Capital: Biotechnologies, Ethics, and Governance in Global Markets. Durham, NC: Duke University Press, pp. 385–436.CrossRefGoogle Scholar
  29. Fitzgerald, J.K. (2014) The continuing significance of race: Racial genomics in a postracial era. Humanity & Society 38(1): 49–66.CrossRefGoogle Scholar
  30. Fosket, J.F. (2004) Constructing ‘high risk’ women: The development and standardization of a breast cancer risk assessment tool. Science, Technology & Human Values 29(3): 291–323.CrossRefGoogle Scholar
  31. Fosket, J.F. (2009) Breast cancer risk as disease. Biomedicalizing risk. In: A.E. Clarke, L. Mamo, J.R. Fosket, J.R. Fishman and J.K. Shim (eds.) Biomedicalization: Technoscientific Transformation of Health, Illness in the U.S. Durham, NC: Duke University Press, pp. 289–306.Google Scholar
  32. Foucault, M. (1994 [1963]) The Birth of the Clinic. New York: Vintage Press.Google Scholar
  33. Fujimura, J. (1987) Constructing ‘do-able’ problems in cancer research: Articulating alignment. Social Studies of Science 17(2): 257–293.CrossRefGoogle Scholar
  34. Fujimura, J.H. (1995) Ecologies of action: Recombining genes, molecularizing cancer, and transforming biology. In: S.L. Star (ed.) Ecologies of Knowledge: Work and Politics in Science and Technology. Albany, NY: State University of New York Press, pp. 302–346.Google Scholar
  35. Gieryn, T.F. (1983) Boundary-work and the demarcation of science from non-science: Strains and interests in professional ideologies of scientists. American Sociological Review 48(6): 781–795.CrossRefGoogle Scholar
  36. Gieryn, T.F. (1995) Boundaries of science. In: S. Jasanoff, G.E. Markle, J.C. Peterson and T. Pinch (eds.) Handbook of Science and Technology Studies. London: Sage, pp. 393–443.Google Scholar
  37. Ginsburg, G.S. and Willard, H.F. (2009) Genomic and personalized medicine: Foundations and applications. Translational Research 154(6): 277–287.CrossRefGoogle Scholar
  38. Goldblatt, E.M. and Lee, W.H. (2010) From bench to bedside: The growing use of translational research in cancer medicine. American Journal of Translational Research 2(1): 1–18.Google Scholar
  39. Hallowell, N., Cooke, S., Crawford, G., Lucassen, A. and Parker, M. (2009a) Distinguishing research from clinical care in cancer genetics: Theoretical justifications and practical strategies. Social Science & Medicine 68(11): 2010–2017.CrossRefGoogle Scholar
  40. Hedgecoe, A. (2004) The Politics of Personalized Medicine: Pharmacogenetics in the Clinic. Cambridge, UK: Cambridge University Press.CrossRefGoogle Scholar
  41. Jones, S.D., Cambrosio, A. and Mogoutov, A. (2011) Detection and characterization of translational research in cancer and cardiovascular medicine. Journal of Translational Medicine 9(57): 1–12.Google Scholar
  42. Kahn, J. (2004) How a drug becomes ‘ethnic’: Law, commerce, and the production of racial categories in medicine. Yale Journal of Health Policy, Law, and Ethics 4(1): 1–46.Google Scholar
  43. Kahn, J. (2010) Surrogate markers and surrogate marketing in biomedicine. The regulatory etiology and commercial progression of ‘ethnic’ drug. In: A.E. Clarke, L. Mamo, J.R. Fosket, J.R. Fishman and J.K. Shim (eds.) Biomedicalization: Technoscientific Transformation of Health, Illness in the U.S. Durham, NC: Duke University Press, pp. 263–287.Google Scholar
  44. Keating, P. and Cambrosio, A. (2003) Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge, MA: MIT Press.Google Scholar
  45. Keating, P. and Cambrosio, A. (2005) Risk on trial. The interaction of innovation and risk factors in clinical trials. In: T. Schlich and U. Tröhler (eds.) The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context. London: Routledge, pp. 225–241.Google Scholar
  46. Keating, P. and Cambrosio, A. (2012) Cancer on Trial. Oncology as a New Style of Practice. Chicago, IL: The University of Chicago Press.Google Scholar
  47. Knorr-Cetina, K. (1981) The Manufacture of Knowledge: An Essay on the Constructivist and Contextual Nature of Science. Oxford: Pergamon Press.Google Scholar
  48. Knorr-Cetina, K. (1999) Epistemic Cultures: How The Sciences Make Knowledge. Cambridge, MA: Harvard University Press.Google Scholar
  49. Kohli-Laven, N., Bourret, P., Keating, P. and Cambrosio, A. (2011) Cancer clinical trials in the era of genomic signatures: Biomedical innovation, clinical utility, and regulatory-scientific hybrids. Social Studies of Science 41(4): 487–513.CrossRefGoogle Scholar
  50. Latimer, J., Featherstone, K., Atkinson, P., Clarke, A., Pilzand, T.D. and Shaw, A. (2006) Rebirthing the clinic: The interaction of clinical judgment and genetic technology in the production of medical science. Science, Technology & Human Values 31(5): 599–630.CrossRefGoogle Scholar
  51. Latour, B. and Woolgar, S. (1979) Laboratory Life: The Social Construction of Scientific Facts. Princeton, NJ: Princeton University Press.Google Scholar
  52. Law, J. (1987) Technologies and heterogeneous engineering: The case of the Portuguese expansion. In: W.E. Bijker, T.P. Hughes and T.J. Pinch (eds.) The Social Construction of Technical Systems: New Directions in the Sociology and History of Technology. Cambridge, MA: MIT Press, pp. 111–134.Google Scholar
  53. Law, J. (2010) The materials of STS. In: D. Hicks and M. Beaudry (eds.) The Oxford Handbook of Material Culture Studies. Oxford: Oxford University Press, pp. 171–186.Google Scholar
  54. Lewis, J., Hughes, J. and Atkinson, P. (2014) Relocation, realignment and standardisation: Circuits of translation in Huntington’s disease. Social Theory and Health 12(4): 396–415.CrossRefGoogle Scholar
  55. Lionelli, S. (2012) When humans are the exception: Cross-species databases at the interface of biological and clinical research. Social Studies of Science 42(2): 214–236.CrossRefGoogle Scholar
  56. Lock, M. (2007) The future is now: Locating biomarkers for dementia. In: R.V. Burri and J. Dumit (eds.) Biomedicine as Culture: Instrumental Practices, Technoscientific Knowledge, and New Modes of Life. New York: Routledge, pp. 61–86.Google Scholar
  57. Lock, M. (2013) Detecting amyloid biomarkers: Embodied risk and Alzheimer prevention. BioSocieties 8(2): 107–123.CrossRefGoogle Scholar
  58. Löwy, I. (1996) Between Bench and Bedside. Science, Healing, and Interlukin-2 in a Cancer Ward. Cambridge, MA: Harvard University Press.Google Scholar
  59. Löwy, I. (2000) Trustworthy knowledge and desperate patients: Clinical tests for new drugs from cancer to AIDS. In: M. Lock, A. Young and A. Cambrosio (eds.) Living and Working with the New Medical Technologies: Intersections of Inquiry. Cambridge, UK: Cambridge University Press, pp. 49–81.CrossRefGoogle Scholar
  60. Lynch, M. (1985) Art and Artifact in Laboratoty Science: A Study of Shop Work and Shop Talk in a Research Laboratory. London: Routledge.Google Scholar
  61. Martin, P., Brown, N. and Kraft, A. (2008) From bedside to bench? Communities of promise, translational research and the making of blood stem cells. Science as Culture 17(1): 29–41.CrossRefGoogle Scholar
  62. Miller, F.A., Ahern, C., Smith, C.A. and Harvey, E.A. (2006) Understanding the new human genetics: A review of scientific editorials. Social Science & Medicine 62(10): 2373–2385.CrossRefGoogle Scholar
  63. Mol, A., Moser, I. and Pols, J. (eds.) (2010) Care in Practice: On Tinkering in Clinics, Homes and Farms. Bielefeld, Germany: Transcript Verlag.CrossRefGoogle Scholar
  64. Moreira, T. (2012) The Transformation of Contemporary Health Care: The Market, The Laboratory, and the Forum. New York: Routledge.Google Scholar
  65. Morgan, M., Barry, A.C., Donovan, J.L., Sandall, J., Wolfe, C. and Boaz, A. (2011) Implementing ‘translational’ biomedical research: Convergence and divergence among clinical and basic scientists. Social Science & Medicine 73(7): 945–952.CrossRefGoogle Scholar
  66. Nelson, N., Keatingand, P. and Cambrosio, A. (2013) On being ‘actionable’: Clinical sequencing and the emerging contours of a regime of genomic medicine in oncology. New Genetics & Society 32(4): 405–428.CrossRefGoogle Scholar
  67. Orlikowski, W. (2007) Sociomaterial practices: Exploring technology at work. Organization Studies 28(9): 1435–1448.CrossRefGoogle Scholar
  68. Perlstadt, H. (2009) Translational research: Enabling the biomedical and social behavioral sciences to benefit society. Humboldt Journal of Social Relations 32(1): 4–34.Google Scholar
  69. Quirke, V. and Gaudillière, J.P. (2008) The era of biomedicine: Science, medicine, and public health in Britain and France after the second world war. Medical History 52(4): 441–452.CrossRefGoogle Scholar
  70. Rose, N. (2001) The politics of life itself. Theory, Culture & Society 18(1): 1–30.CrossRefGoogle Scholar
  71. Rose, N. (2007) The Politics of Life Itself. Biomedicine, Power, and Subjectivity in the Twenty-First Century. Princeton, NJ: Princeton University Press.Google Scholar
  72. Rose, N. (2013) The human sciences in a biological age. Theory, Culture & Society 30(1): 3–34.CrossRefGoogle Scholar
  73. Rosser, S. (2000) Controversies in breast cancer research. In: A.S. Kasper and S.J. Ferguson (eds.) Breast Cancer: Society Shapes an Epidemic. New York: St. Martin’s Press, pp. 245–270.CrossRefGoogle Scholar
  74. Shanks, N., Greek, R. and Greek, J. (2009) Are animal models predictive for humans? Philosophy, Ethics, and Humanities in Medicine 4(2): 1–20.Google Scholar
  75. Snow, C.P. (1993) The Two Cultures. Cambridge, UK: Cambridge University Press.CrossRefGoogle Scholar
  76. Star, S.L. (1989) The structure of ill-structured solutions: Boundary objects and heterogeneous distributed problem solving. In: M. Huhns and L. Gasser (eds.) Distributed Artificial Intelligence. Menlo Park, CA: Morgan Kaufmann Publishing, pp. 37–54.Google Scholar
  77. Star, S.L. and Griesemer, J.R. (1989) Institutional ecology, ‘translations’ and boundary objects: Amateurs and professionals in Berkeley’s museum of vertebrate zoology, 1907–39. Social Studies of Science 19(3): 387–420.CrossRefGoogle Scholar
  78. Star, S.L. (1999) The ethnography of infrastructure. American Behavioral Scientist 43(3): 377–391.CrossRefGoogle Scholar
  79. Suchman, L. (2000) Organizing alignment: A case of bridge – Building. Organization 7(2): 311–329.CrossRefGoogle Scholar
  80. Sulik, A.G. (2009) Managing biomedical uncertainty: The technoscientific illness identity. Sociology of Health & Illness 31(7): 1059–1076.CrossRefGoogle Scholar
  81. Taussig, K.S., Hoeyer, K. and Helmreich, S. (2013) The anthropology of potentiality in biomedicine: an introduction to supplement 7. Current Anthropology 54(suppl. 7): S3–S14.CrossRefGoogle Scholar
  82. Thacker, E. (2005) The Global Genome: Biotechnology, Politics, and Culture. Cambridge, MA: MIT Press.Google Scholar
  83. Timmermans, S. and Berg, M. (2003) The practice of medical technology. Sociology of Health & Illness 25(3): 97–114.CrossRefGoogle Scholar
  84. Tutton, R. (2012) Personalizing medicine: Futures present and past. Social Science & Medicine 75(10): 1721–1728.CrossRefGoogle Scholar
  85. van den Hoonaard, D.K. (2009) Moving toward a three-way intersection in translational research: A sociological perspective. Qualitative Health Research 19(12): 1783–1787.CrossRefGoogle Scholar
  86. Wainwright, S.P., Williams, C., Michael, M. and Cribb, A. (2009) Stem cells, translational research and the sociology of science. In: P. Atkinson, P. Glasner and M. Lock (eds.) Handbook of Genetics & Society: Mapping the New Genomic Era. London: Routledge, pp. 41–58.Google Scholar
  87. Wainwright, S.P., Williams, C., Michael, M., Farsides, B. and Cribb, A. (2006) From bench to bedside? Biomedical scientists’ expectations of stem cell science as future therapy for diabetes. Social Science and Medicine 63(8): 2052–2064.CrossRefGoogle Scholar
  88. Webster, A., Martin, P., Lewis, G. and Smart, A. (2004) Integrating pharmacogenetics into society: In search of a model. Nature Reviews Genetics 5(9): 7–13.CrossRefGoogle Scholar
  89. Zerhouni, E.A. (2007) Translational research: Moving discovery to practice. Clinical Pharmacology & Therapeutics 81(1): 126–128.CrossRefGoogle Scholar

Copyright information

© Macmillan Publishers Ltd 2016

Authors and Affiliations

  1. 1.Department of Philosophy, Sociology, Education and Applied Psychology (FISPPA), University of PaduaPadovaItaly

Personalised recommendations